Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 109,382,312
  • Shares Outstanding, K 2,027,100
  • Annual Sales, $ 45,006,000,000
  • Annual Income, $ 8,025,000,000
  • 60-Month Beta 0.46
  • Price/Sales 2.44
  • Price/Cash Flow 4.35
  • Price/Book 6.44
Trade BMY with:

Options Overview Details

View History
  • Implied Volatility 31.77% ( +1.18%)
  • Historical Volatility 19.76%
  • IV Percentile 95%
  • IV Rank 72.94%
  • IV High 36.85% on 07/11/24
  • IV Low 18.09% on 11/03/23
  • Put/Call Vol Ratio 0.68
  • Today's Volume 17,011
  • Volume Avg (30-Day) 57,029
  • Put/Call OI Ratio 1.01
  • Today's Open Interest 735,604
  • Open Int (30-Day) 804,412

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 1.57
  • Number of Estimates 10
  • High Estimate 1.66
  • Low Estimate 1.50
  • Prior Year 2.00
  • Growth Rate Est. (year over year) -21.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.55 +13.80%
on 09/09/24
54.54 -0.79%
on 10/02/24
+5.41 (+11.11%)
since 09/06/24
3-Month
39.50 +36.99%
on 07/08/24
54.54 -0.79%
on 10/02/24
+14.45 (+36.43%)
since 07/05/24
52-Week
39.35 +37.51%
on 07/05/24
57.65 -6.13%
on 10/17/23
-2.55 (-4.50%)
since 10/06/23

Most Recent Stories

More News
2 Passive-Income Stocks to Load Up On in October

These two dividend powerhouses are ideal choices for passive-income investors.

LMT : 608.71 (+0.59%)
BMY : 54.02 (+0.11%)
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday

Changes are afoot at the company, and investors welcomed them.

PRME : 3.60 (+2.56%)
BMY : 54.02 (+0.11%)
3 Surprisingly Underrated Stocks to Buy Right Now

These stocks might look like bad picks. But appearances can be deceiving.

MRNA : 59.22 (-1.63%)
PFE : 29.32 (+2.59%)
BMY : 54.02 (+0.11%)
Stocks Settle Lower on Weakness in Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) Friday closed down by -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.53%. Stocks...

AMAT : 200.86 (-0.55%)
AVGO : 176.82 (+0.10%)
INTU : 606.10 (-0.75%)
HPQ : 35.94 (-0.14%)
WYNN : 106.03 (+0.55%)
$IUXX : 19,949.65 (-0.43%)
AMGN : 317.81 (-0.58%)
ASML : 819.36 (-1.64%)
ZNZ24 : 112-160 (-0.30%)
COST : 878.68 (-0.50%)
QCOM : 167.48 (-0.84%)
LRCX : 80.89 (-0.80%)
Inflation Report Sparks Mixed Market Reaction

The S&P 500 Index ($SPX ) (SPY ) today is down by +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.45%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.36%. Stocks today are mixed,...

AVGO : 176.82 (+0.10%)
INTU : 606.10 (-0.75%)
HPQ : 35.94 (-0.14%)
WYNN : 106.03 (+0.55%)
$IUXX : 19,949.65 (-0.43%)
AMGN : 317.81 (-0.58%)
ASML : 819.36 (-1.64%)
ZNZ24 : 112-160 (-0.30%)
COST : 878.68 (-0.50%)
LRCX : 80.89 (-0.80%)
$DOWI : 42,088.13 (-0.62%)
SPY : 570.57 (-0.42%)
Dow Jones Climbs to New Record Highs, While the Nasdaq Slides

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.93%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.30%. Stocks today are mixed,...

INTU : 606.10 (-0.75%)
$SPX : 5,727.51 (-0.41%)
ADI : 225.91 (-1.02%)
NXPI : 234.88 (+0.27%)
SMMT : 18.76 (-1.73%)
HPQ : 35.94 (-0.14%)
WYNN : 106.03 (+0.55%)
TMDX : 135.71 (-2.35%)
$IUXX : 19,949.65 (-0.43%)
AMGN : 317.81 (-0.58%)
BMY : 54.02 (+0.11%)
QQQ : 485.18 (-0.44%)
FDA Approves Bristol Myers Squibb’s Schizophrenia Medication

The U.S. Food and Drug Administration (FDA) has approved pharmaceutical company Bristol Myers Squibb’s ...

BMY : 54.02 (+0.11%)
Analysts Think There's Still Time to Get in on Edgewise, Up 332%

Edgewise Therapeutics was a massive winner last week after positive results on its cardiovascular treatment. This there still room for the stock to run?

CYTK : 56.28 (-0.71%)
EWTX : 26.93 (-5.18%)
BMY : 54.02 (+0.11%)
Sanofi's Sarclisa Gets FDA Nod for Expanded Use in Multiple Myeloma

Sanofi SNY announced that the FDA has approved the label expansion for the use of its multiple myeloma (MM) drug, Sarclisa (isatuximab).With this nod, Sarclisa is now approved in combination with Velcade...

JNJ : 160.18 (-0.07%)
REGN : 995.86 (-1.67%)
SNY : 55.01 (-0.83%)
BMY : 54.02 (+0.11%)
3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade

Now could be a great time to scoop up three stocks trading way below their previous peaks.

BEP : 26.78 (-1.98%)
RPRX : 27.68 (-0.25%)
BMY : 54.02 (+0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 54.93
2nd Resistance Point 54.47
1st Resistance Point 54.21
Last Price 54.02
1st Support Level 53.50
2nd Support Level 53.04
3rd Support Level 52.79

See More

52-Week High 57.65
Last Price 54.02
Fibonacci 61.8% 50.66
Fibonacci 50% 48.50
Fibonacci 38.2% 46.34
52-Week Low 39.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar